The alopecia treatment (hair loss) industry will relinquish an approximated estimate at a frequency of 6.0% for the projection space of 2020 to 2027 with factor such as the increase in geriatric population and rise in prevalence of alopecia conditions. Increase in prevalence of chemotherapy induced alopecia and increasing level of stress also acts as a major factor for the growth of the alopecia treatment (hair loss) market. Changing lifestyle has also given a boom to the global alopecia treatment (hair loss) market.

Technological advancements in hair treatment medical devices have propelled the demand of the alopecia treatment (hair loss) market. However, side effects associated with the available hair loss treatment therapies and high costs of therapies have decreased the demand of the alopecia treatment (hair loss) market.

Global Alopecia Treatment (Hair Loss) Market Scenario            

According to Data Bridge Market Research, the market for alopecia treatment (hair loss) in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Johnson & Johnson Services, Inc. which accounts an estimated market share of approximately 10.88% in the global market. The company has gained outstanding sales by providing advanced therapies for alopecia treatment (hair loss).  

• In March 2018, Johnson & Johnson Services, Inc. and JW Pharmaceutical teamed up with an aim to earn more product sales of Rogaine, a hair loss treatment containing minoxidil. Along with this, an exclusive distributorship agreement has been signed by the JW Pharmaceutical with Johnson & Johnson Services, Inc. in November 2017. Rogaine is a FDA approved hair loss treatment and has earned position among the top selling alopecia treatment brands. This initiative thus boosted the company’s revenue.

Trends Impacting the Alopecia Treatment (Hair Loss) Market

Now the question is which other regions Johnson & Johnson Services, Inc., GlaxoSmithKline plc and Taisho Pharmaceutical Holdings Co., Ltd. are targeting? Data Bridge Market Research has forecasted a large growth in North America alopecia treatment (hair loss) market and the market leaders targeting the U.S., Canada to be their next revenue pocket for 2020.

The alopecia treatment (hair loss) market is becoming more competitive with companies such as the Johnson & Johnson Services, Inc., GlaxoSmithKline plc and Taisho Pharmaceutical Holdings Co., Ltd. These are the top dominating companies in alopecia treatment (hair loss) market and are launching more new therapies in the alopecia treatment (hair loss) market. The Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global alopecia treatment (hair loss) market.

For more analysis on the global alopecia treatment (hair loss) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-alopecia-treatment-hair-loss-market

New Alopecia Treatment (Hair Loss) Market Development

• In March 2018, GlaxoSmithKline plc received successful sales of Avodart, a hair loss treatment in Japan. This company has achieved this much high sales during the same year, the generic drug of Avodart has been launched which thus allowed the company to maximize the revenue growth and to penetrate in several regions which has comprised the alopecia treatment (hair loss).

Scope of the Global Alopecia Treatment (Hair Loss) Market

Global alopecia treatment (hair loss) market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

• All country based analysis of the global alopecia treatment (hair loss) market is further analyzed based on maximum granularity into further segmentation. On the basis of disease type, the alopecia treatment (hair loss) market is segmented into non-cicatricial alopecia, cicatricial alopecia, traction alopecia and others. On the basis of treatment, the alopecia treatment (hair loss) market is segmented into localized therapies, systemic therapies, medical devices and herbal treatment. On the basis of gender, the alopecia treatment (hair loss) market is segmented into male and female. On the basis of form, the alopecia treatment (hair loss) market is segmented into oral, topical and parenteral. On the basis of end user, the alopecia treatment (hair loss) market is segmented into hospitals, home healthcare and dermatology centers. On the basis of distribution channel, the alopecia treatment (hair loss) market is segmented into direct tender, retail sales and pharmacies.

To know more about the study https://www.databridgemarketresearch.com/reports/global-alopecia-treatment-hair-loss-market

Key Pointers Covered in Global Alopecia Treatment (Hair Loss) Market Industry Trends and Forecast to 2027

• Market Size
• Top to Bottom Market Analysis
• Recent Developments for Market Competitors
• Recent Market Value for Different Countries
• Market Value and Over View of Alopecia Treatment (Hair Loss) Market
• Company Profiling of Top Eight Players of Alopecia Treatment (Hair Loss) Market

Key Market Competitors Covered in the Report

• Alès Groupe
• Gerolymatos International SA
• iGrow Laser
• Lexington Intl., LLC.
• Curallux, LLC.
• Follicum AB
• HCell Inc.
• Freedom Laser Therapy, Inc.
• Taisho Pharmaceutical Holdings Co., Ltd.
• Vita-Cos-Med Klett-Loch GmbH
• Vitabiotics Ltd.
• WOCKHARDT
• Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceuticals Industries Ltd.)
• Pfizer Inc.
• Par Pharmaceutical (a subsidiary of Endo International plc)
• GlaxoSmithKline plc
• Dr. Reddy’s Laboratories Ltd.
• Abbott
• Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
• Johnson & Johnson Services, Inc.
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.)
• Aurobindo Pharma
• Perrigo Company plc
• Viviscal Limited (a subsidiary of Church & Dwight Co., Inc.)
• Dr. Kurt Wolff GmbH & Co. KG
• Nanogen
• Labo International S.r.l.
• Watermans
• WON TECH Co., Ltd.
• PureTech

Above are the key players covered in the report, to know about more and exhaustive list of alopecia treatment (hair loss) companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-alopecia-treatment-hair-loss-market

Research Methodology: Global Alopecia Treatment (Hair Loss) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

• Demand Side: Manufacturers, Healthcare Industrialists, Dermatologists, Scientists, Research Laboratories
• Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers

Related Reports

• Global Dermatology Treatment Devices Market - Industry Trends and Forecast to 2027
• Global Alopecia Areata Market - Industry Trends and Forecast to 2027

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/